Slo-phyllin vs. Accolate: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Slo-phyllin and Accolate. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 33,731 people who take Slo-phyllin and Accolate, and is updated regularly.
What is Slo-phyllin?
Slo-phyllin has active ingredients of theophylline. It is often used in asthma. eHealthMe is studying from 113 Slo-phyllin users. Check the latest studies of Slo-phyllin.
What is Accolate?
Accolate has active ingredients of zafirlukast. It is often used in asthma. eHealthMe is studying from 4,220 Accolate users. Check the latest studies of Accolate.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
33,731 people who take Slo-phyllin and Accolate are studied.
Drugs being compared in this study:
- Accolate (zafirlukast)
- Slo-Phyllin (theophylline)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Slo-Phyllin:
- not at all: 4.31 %
- somewhat: 12.07 %
- moderate: 25.86 %
- high: 36.21 %
- very high: 21.55 %
Accolate:
- not at all: 2.08 %
- somewhat: 18.75 %
- moderate: 27.08 %
- high: 33.33 %
- very high: 18.75 %
Want to compare Slo-phyllin with Accolate?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
- Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
- Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
- Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Slo-phyllin (109 reports)
- Accolate (4,148 reports)
Browse all side effects of Slo-phyllin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Accolate:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on theophylline and zafirlukast (the active ingredients of Slo-phyllin and Accolate, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Famotidine and Back Pain for Men aged 60+ - 12 seconds ago
- Famotidine and Nonspecific Back Pain for Men aged 60+ - 12 seconds ago
- Famotidine and Pain - Back for Men aged 60+ - 12 seconds ago
- Famotidine and Back Pain - Nonspecific for Men aged 60+ - 13 seconds ago
- Could Restoril cause Tenderness? - 30 seconds ago
- Could Kenalog cause Insomnia? - 40 seconds ago
- Could Avinza cause Confusion? - 42 seconds ago
- Codeine, Aspirin, Apap Formula No. 2 vs. Dayquil, side effect and effectiveness comparison - 48 seconds ago
- Could Juluca cause Anhedonia? - a minute ago
- Could Valsartan cause Dermatitis Exfoliative Generalised? - a minute ago